S. Nayak

发表

Correlation of clinicopathological outcomes with changes in IHC4 status after NACT in locally advanced breast cancers: do pre-NACT ER/PR status act as better prognosticators?

I. Arun, R. Ahmed, S. Chatterjee, 2015, Breast cancer.

Bone Morphogenetic Protein 4 Targeting Glioma 2 Stem-Like Cells for Malignant Glioma Treatment: 3 Latest Advances and Implications for Clinical 4 Application

C. James, J. Kessler, Shi-Yuan Cheng, 2020 .

Bone Morphogenetic Protein 4 Targeting Glioma Stem-Like Cells for Malignant Glioma Treatment: Latest Advances and Implications for Clinical Application

C. James, S. Stupp, Mark T. McClendon, 2020, Cancers.

Prevalence estimation of microsatellite instability in colorectal cancers using tissue microarray based methods – A tertiary care center experience

M. Roy, I. Arun, Sudeep Banerjee, 2018, Indian journal of pathology & microbiology.

Bone morphogenetic protein 4 reduces global H3K4me3 to inhibit proliferation and promote differentiation of human neural stem cells

C. James, J. Kessler, T. Tomita, 2020, bioRxiv.

Title: WDR82 mediated H3K4me3 is associated with tumor proliferation and therapeutic efficacy in pediatric high-grade gliomas Running title: WDR82 mediated H3K4me3 in pediatric gliomas

C. James, T. Tomita, C. Jie, 2022 .

Distinct patterns of occurrence, common associations, and survival of patients with second primary maligancies: A 5-year single institute experience with review of literature.

R. Digumarti, S. Nayak, L. Digumarti, 2021, Indian journal of pathology & microbiology.

WDR82 mediated H3K4me3 is associated with tumor proliferation and therapeutic efficacy in pediatric high-grade gliomas

C. James, T. Tomita, C. Jie, 2022, bioRxiv.

Correlation of clinicopathological outcomes with changes in IHC4 status after NACT in locally advanced breast cancers: do pre-NACT ER/PR status act as better prognosticators?

I. Arun, R. Ahmed, S. Chatterjee, 2015, Breast cancer.